Differences in local immune cell landscape between Q fever and atherosclerotic abdominal aortic aneurysms identified by multiplex immunohistochemistry

  1. Kimberley RG Cortenbach
  2. Alexander HJ Staal
  3. Teske Schoffelen
  4. Mark AJ Gorris
  5. Lieke L Van der Woude
  6. Anne FM Jansen
  7. Paul Poyck
  8. Robert Jan Van Suylen
  9. Peter C Wever
  10. Chantal P Bleeker-Rovers
  11. Mangala Srinivas
  12. Konnie M Hebeda
  13. Marcel van Deuren
  14. Jos W Van der Meer
  15. Jolanda M De Vries
  16. Roland RJ Van Kimmenade  Is a corresponding author
  1. Radboud Institute for Molecular Life Sciences, Netherlands
  2. Radboud University Medical Centre, Netherlands
  3. Jeroen Bosch Ziekenhuis, Netherlands
  4. Radboud University Medical Center, Netherlands

Abstract

Background: Chronic Q fever is a zoonosis caused by the bacterium Coxiella burnetii which can manifest as infection of an abdominal aortic aneurysm (AAA). Antibiotic therapy often fails, resulting in severe morbidity and high mortality. Whereas previous studies have focused on inflammatory processes in blood, the aim of this study was to investigate local inflammation in aortic tissue.

Methods: Multiplex immunohistochemistry was used to investigate local inflammation in Q fever AAAs compared to atherosclerotic AAAs in aorta tissue specimen. Two six-plex panels were used to study both the innate and adaptive immune system.

Results: Q fever AAAs and atherosclerotic AAAs contained similar numbers of CD68+ macrophages and CD3+ T cells. However, in Q fever AAAs the number of CD68+CD206+ M2 macrophages was increased, while expression of GM-CSF was decreased compared to atherosclerotic AAAs. Furthermore, Q fever AAAs showed an increase in both the number of CD8+ cytotoxic T cells and CD3+CD8-FoxP3+ regulatory T cells. Lastly, Q fever AAAs did not contain any well-defined granulomas.

Conclusions: These findings demonstrate that despite the presence of pro-i is associated with an immune suppressed micro environment.

Funding: This work was supported by SCAN consortium: European Research Area - CardioVascualar Diseases (ERA-CVD) grant [JTC2017-044] and TTW-NWO open technology grant [STW-14716].

Data availability

All data generated or analyzed during this study are included in the manuscript and uploaded to Dryad (http://dx.doi.org/10.5061/dryad.bzkh189b4).Figure 3 - Source data 3; Figure 5 - Source data 5; Figure 6 - Source figure 6; Figure 7 - Source figure 7 contain numerical data used to generate the figures.

The following data sets were generated
    1. Cortenbach KR
    (2021) Vascular Q fever inflammation
    Dryad Digital Repository, doi:10.5061/dryad.bzkh189b4.

Article and author information

Author details

  1. Kimberley RG Cortenbach

    Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2717-5527
  2. Alexander HJ Staal

    Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  3. Teske Schoffelen

    Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  4. Mark AJ Gorris

    Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  5. Lieke L Van der Woude

    Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  6. Anne FM Jansen

    Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  7. Paul Poyck

    Department of Surgery, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  8. Robert Jan Van Suylen

    Department of Pathology, Jeroen Bosch Ziekenhuis, 's Hertogenbosch, Netherlands
    Competing interests
    No competing interests declared.
  9. Peter C Wever

    Department of Medical Microbiology and Infection Control, Jeroen Bosch Ziekenhuis, 's Hertogenbosch, Netherlands
    Competing interests
    No competing interests declared.
  10. Chantal P Bleeker-Rovers

    Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  11. Mangala Srinivas

    Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  12. Konnie M Hebeda

    Department of Pathology, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4181-3302
  13. Marcel van Deuren

    Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  14. Jos W Van der Meer

    Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    Jos W Van der Meer, Senior editor, eLife.
  15. Jolanda M De Vries

    Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  16. Roland RJ Van Kimmenade

    Department of Pathology, Radboud University Medical Centre, Nijmegen, Netherlands
    For correspondence
    Roland.vanKimmenade@radboudumc.nl
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8207-8906

Funding

European Research Area - Cardiovascular Diseases (JTC2017-044)

  • Kimberley RG Cortenbach

TTW-NWO Open Technology (STW-14716)

  • Alexander HJ Staal

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The medical ethics committees of the institutions approved the study, in line with the principlesoutlined in the Declaration of Helsinki (Radboudumc: 2017-3196; Jeroen Bosch Hospital:2019.05.02.01).

Copyright

© 2022, Cortenbach et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 603
    views
  • 95
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Kimberley RG Cortenbach
  2. Alexander HJ Staal
  3. Teske Schoffelen
  4. Mark AJ Gorris
  5. Lieke L Van der Woude
  6. Anne FM Jansen
  7. Paul Poyck
  8. Robert Jan Van Suylen
  9. Peter C Wever
  10. Chantal P Bleeker-Rovers
  11. Mangala Srinivas
  12. Konnie M Hebeda
  13. Marcel van Deuren
  14. Jos W Van der Meer
  15. Jolanda M De Vries
  16. Roland RJ Van Kimmenade
(2022)
Differences in local immune cell landscape between Q fever and atherosclerotic abdominal aortic aneurysms identified by multiplex immunohistochemistry
eLife 11:e72486.
https://doi.org/10.7554/eLife.72486

Share this article

https://doi.org/10.7554/eLife.72486

Further reading

    1. Medicine
    2. Neuroscience
    Joanna Kosinska, Julian C Assmann ... Markus Schwaninger
    Research Article

    Monomethyl fumarate (MMF) and its prodrug dimethyl fumarate (DMF) are currently the most widely used agents for the treatment of multiple sclerosis (MS). However, not all patients benefit from DMF. We hypothesized that the variable response of patients may be due to their diet. In support of this hypothesis, mice subjected to experimental autoimmune encephalomyelitis (EAE), a model of MS, did not benefit from DMF treatment when fed a lauric acid-rich (LA) diet. Mice on normal chow (NC) diet, in contrast, and even more so mice on high-fiber (HFb) diet showed the expected protective DMF effect. DMF lacked efficacy in the LA diet-fed group despite similar resorption and preserved effects on plasma lipids. When mice were fed the permissive HFb diet, the protective effect of DMF treatment depended on hydroxycarboxylic receptor 2 (HCAR2) which is highly expressed in neutrophil granulocytes. Indeed, deletion of Hcar2 in neutrophils abrogated DMF protective effects in EAE. Diet had a profound effect on the transcriptional profile of neutrophils and modulated their response to MMF. In summary, DMF required HCAR2 on neutrophils as well as permissive dietary effects for its therapeutic action. Translating the dietary intervention into the clinic may improve MS therapy.

    1. Medicine
    Hyun Beom Song, Laura Campello ... Anand Swaroop
    Research Advance

    Inherited retinal degenerations (IRDs) constitute a group of clinically and genetically diverse vision-impairing disorders. Retinitis pigmentosa (RP), the most common form of IRD, is characterized by gradual dysfunction and degeneration of rod photoreceptors, followed by the loss of cone photoreceptors. Recently, we identified reserpine as a lead molecule for maintaining rod survival in mouse and human retinal organoids as well as in the rd16 mouse, which phenocopy Leber congenital amaurosis caused by mutations in the cilia-centrosomal gene CEP290 (Chen et al., 2023). Here, we show the therapeutic potential of reserpine in a rhodopsin P23H rat model of autosomal dominant RP. At postnatal day (P) 68, when males and females are analyzed together, the reserpine-treated rats exhibit higher rod-derived scotopic b-wave amplitudes compared to the controls with little or no change in scotopic a-wave or cone-derived photopic b-wave. Interestingly, the reserpine-treated female rats display enhanced scotopic a- and b-waves and photopic b-wave responses at P68, along with a better contrast threshold and increased outer nuclear layer thickness. The female rats demonstrate better preservation of both rod and cone photoreceptors following reserpine treatment. Retinal transcriptome analysis reveals sex-specific responses to reserpine, with significant upregulation of phototransduction genes and proteostasis-related pathways, and notably, genes associated with stress response. This study builds upon our previously reported results reaffirming the potential of reserpine for gene-agnostic treatment of IRDs and emphasizes the importance of biological sex in retinal disease research and therapy development.